StockData
Aquestive Therapeutics, Inc. logo

Aquestive Therapeutics, Inc. (AQST) stock

AQSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 3/30
$3.70−0.06 (-1.60%)

Close on Nov 17, 2026Market cap $464.39MP/E –Yield –

Aquestive Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Aquestive Therapeutics's profit margin for the twelve months ending Jun 30, 2026 was -144.6%. For fiscal 2025 it was -188.1%, against -76.7% the year before. The highest annual figure on record is -13.4% in fiscal 2017.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-188.1%−111.4
FY2024Dec 31, 2024-76.7%−61.1
FY2023Dec 31, 2023-15.6%+98.6
FY2022Dec 31, 2022-114.1%+24.7
FY2021Dec 31, 2021-138.8%−17.1
FY2020Dec 31, 2020-121.7%+4.3
FY2019Dec 31, 2019-125.9%−34.9
FY2018Dec 31, 2018-91.0%−77.7
FY2017Dec 31, 2017-13.4%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-165.5%−30.0
Q1 FY2026Mar 31, 2026-55.8%+207.2
Q4 FY2025Dec 31, 2025-244.8%−101.1
Q3 FY2025Sep 30, 2025-120.6%−35.6
Q2 FY2025Jun 30, 2025-135.4%−121.8
Q1 FY2025Mar 31, 2025-263.0%−156.5
Q4 FY2024Dec 31, 2024-143.7%−82.3
Q3 FY2024Sep 30, 2024-85.0%−69.3
Q2 FY2024Jun 30, 2024-13.7%+30.1
Q1 FY2024Mar 31, 2024-106.4%−178.9
Q4 FY2023Dec 31, 2023-61.4%+54.2
Q3 FY2023Sep 30, 2023-15.7%+93.7
Q2 FY2023Jun 30, 2023-43.7%+79.2
Q1 FY2023Mar 31, 202372.5%+180.2
Q4 FY2022Dec 31, 2022-115.6%+145.6
Q3 FY2022Sep 30, 2022-109.4%+0.2
Q2 FY2022Jun 30, 2022-122.9%−42.3
Q1 FY2022Mar 31, 2022-107.7%+24.2
Q4 FY2021Dec 31, 2021-261.3%+23.6
Q3 FY2021Sep 30, 2021-109.5%+90.8
Q2 FY2021Jun 30, 2021-80.6%−69.8
Q1 FY2021Mar 31, 2021-131.9%+56.7
Q4 FY2020Dec 31, 2020-284.9%−207.9
Q3 FY2020Sep 30, 2020-200.4%−52.1
Q2 FY2020Jun 30, 2020-10.8%+173.2
Q1 FY2020Mar 31, 2020-188.6%−72.1
Q4 FY2019Dec 31, 2019-77.0%+5.9
Q3 FY2019Sep 30, 2019-148.3%−165.8
Q2 FY2019Jun 30, 2019-184.0%−101.6
Q1 FY2019Mar 31, 2019-116.5%−147.6
Q4 FY2018Dec 31, 2018-82.9%−30.0
Q1 FY2018Mar 31, 201817.5%+26.4
Q4 FY2017Dec 31, 2017-82.3%–
Q3 FY2017Sep 30, 201731.1%–
Q2 FY2017Jun 30, 2017-52.9%–
Q1 FY2017Mar 31, 2017-8.9%–

More Aquestive Therapeutics figures

See a number that looks wrong?